TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Shire sends Gaucher drug to FDA Shire PLC has sent its treatment for Gaucher disease, an alternative to the Genzyme drug Cerezyme, to the FDA for approval. feeds.bizjournals.com |
Obama Used Faulty Anecdote Obama used a faulty anecdote in his speech to Congress in referencing an Illinois man dropped from his insurance plan. online.barrons.com |
Clinuvel: Three Prospective Game Changing Events in Three Months Clinuvel Pharmaceuticals (CLVLY.PK) is expecting to report on key binary events in the coming months – and as of right now, these binary events are flying under the radar in the biotech investing world. This presents an intriguing opportunity for those investors who are looking for a high risk / high potential reward play in biotech. These events will be game changers – and they are all right around the corner. Let’s preview them:Complete Story » seekingalpha.com |
Health-Coverage Mandate Under Fire Conservatives have opened a new front in the health-care debate with the assertion that under the Democrats' plan, people who refuse to buy insurance could spend five years in prison. online.wsj.com |
5 Value Stocks Worth Considering Scott's Investments submits:I have taken a recent interest in running deep value screens in an attempt to expand my investing horizons beyond the basic trend following and momentum systems I regularly track on Scott's Investments. Yesterday's screen looked for stocks trading below book value with low debt, high relative cash, cash flow, and forward earnings. Today's screen is an expansion of that screen with some added criteria: Forward P/E > 0 Price/Cash < 3 Price/Free Cash Flow < 15 Debt/Equity < .4 Price/Book < 1 Current Ratio > 3 Return on Assets > 0% Return on Equity > 0% Annual EPS Growth Next 5 Years > 0Complete Story » seekingalpha.com |